Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × dabrafenib × 30 days × Clear all

Sponsor

Conditions

Melanoma 5 Multiple Myeloma 4 Thyroid Carcinoma, Anaplastic 2 Neoplasms 2 Hematologic Neoplasms 2 Glioma 2 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Laryngeal Neoplasms 1 Histiocytosis, Langerhans-Cell 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Erdheim-Chester Disease 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Astrocytoma 1

Interventions

Gemcitabine 6 durvalumab 5 Cisplatin 5 Nivolumab 3 Liquid Biopsy 3 pembrolizumab 2 lenvatinib 2 S 1 (combination) 2 Oxaliplatin 2 Carboplatin 2 Bevacizumab 2 zanidatamab 1 trifluridine tipiracil drug combination 1 mitazalimab 1 gemcitabine-oxaliplatin regimen 1 Tegafur 1 Standard of Care 1 Paclitaxel 1 Leucovorin 1 Injections 1 Immune Checkpoint Inhibitors 1 Folfox protocol 1 Fluorouracil 1 Drug Therapy 1 Circulating Tumor DNA 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Blood Specimen Collection 1 Base Sequence 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡